Cited by 1,424Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 223 of the 225 references it cites were found in a registry or an index.

Alzheimer’s Disease: The Challenge of the Second Century

Open access

Holtzman, David M., Morris, John C., Goate, Alison M.·2011·Science Translational Medicine

DOI 10.1126/scitranslmed.3002369PMC PMC3130546

Open this paper in CoChat — free account

Abstract

In the first of our State of the Art Review series, David M. Holtzman, John C. Morris, and Alison M. Goate explore the rapid pace of Alzheimer’s disease research and the challenges to translating research breakthroughs into clinical treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3002369

Cites

223 of 223 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
Retracted
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806

Show all 225 references

Sorted by citations

Items 301–400 of 1,001

Fate and propagation of endogenously formed Tau aggregates in neuronal cells
Chastagner, P., Loría, F., Vargas, J., Tois, J., Diamond, M. I., Okafo, G. N., Brou, C., & Zurzolo, C. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012025 · Cited by 80
Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice
Huang, H., Nie, S., Cao, M., Marshall, C., Gao, J., Xiao, N., Hu, G., & Xiao, M. (2016) · AGE · doi:10.1007/s11357-016-9929-7 · Cited by 79
Glial Draper Rescues Aβ Toxicity in aDrosophilaModel of Alzheimer's Disease
Ray, A., Speese, S. D., & Logan, M. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0862-17.2017 · Cited by 79
Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease
Hashemiaghdam, A., & Mroczek, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577185 · Cited by 79
Screening Flavonoids for Inhibition of Acetylcholinesterase Identified Baicalein as the Most Potent Inhibitor
Balkis, A., Tran, K., Lee, Y. Z., & Ng, K. (2015) · Journal of Agricultural Science · doi:10.5539/jas.v7n9p26 · Cited by 78
Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice
Buskila, Y., Crowe, S. E., & Ellis-Davies, G. C. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.016 · Cited by 77
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss
Salazar, S. V., Cox, T. O., Lee, S., Brody, A. H., Chyung, A. S., Haas, L. T., & Strittmatter, S. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1873-18.2018 · Cited by 77
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model
LaClair, K. D., Donde, A., Ling, J. P., Jeong, Y. H., Chhabra, R., Martin, L. J., & Wong, P. C. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1637-y · Cited by 76
Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms
Khanna, S., Domingo‐Fernándéz, D., Iyappan, A., Emon, M. A., Hofmann‐Apitius, M., & Fröhlich, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-29433-3 · Cited by 76
Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer’s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways
Khan, M. I., Jeong, E. S., Khan, M. Z., Shin, J. H., & Kim, J. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-42485-4 · Cited by 77
Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Cameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1729-12.2012 · Cited by 76
18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease
Bouter, C., Henniges, P., Franke, T. N., Irwin, C., Sahlmann, C. O., Sichler, M. E., Beindorff, N., Bayer, T. A., & Bouter, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00425 · Cited by 77
The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer’s disease phenotype
Joshi, Y. B., & Praticò, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00436 · Cited by 75
Early Diagnosis of Alzheimer’s Disease in Blood Using a Disposable Electrochemical Microfluidic Platform
de Oliveira, T. R., Erbereli, C. R., Manzine, P. R., Magalhães, T. N. C., Balthazar, M. L. F., Cominetti, M. R., & Faria, R. C. (2020) · ACS Sensors · doi:10.1021/acssensors.9b02463 · Cited by 74
An integrated study of the affinities of the Aβ16 peptide for Cu( i ) and Cu( ii ): implications for the catalytic production of reactive oxygen species
Young, T. R., Kirchner, A., Wedd, A. G., & Xiao, Z. (2014) · Metallomics · doi:10.1039/c4mt00001c · Cited by 74
Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator
Takeo, K., Tanimura, S., Shinoda, T., Osawa, S., Zahariev, I. K., Takegami, N., Ishizuka‐Katsura, Y., Shinya, N., Takagi‐Niidome, S., Tominaga, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402171111 · Cited by 74
Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease
Takeda, S., Hashimoto, T., Roe, A. D., Hori, Y., Spires‐Jones, T. L., & Hyman, B. T. (2013) · The FASEB Journal · doi:10.1096/fj.13-229666 · Cited by 74
Visual system manifestations of Alzheimer's disease
Kusne, Y. N., Wolf, A. B., Townley, K., Conway, M. D., & Peyman, G. A. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13319 · Cited by 74
Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage
Sotolongo, K., Ghiso, J. A., & Rostagno, A. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0578-9 · Cited by 74
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73
Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease
Storck, S. E., & Pietrzik, C. U. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2267-3 · Cited by 74
Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
Cascio, F. L., Puangmalai, N., Ellsworth, A., Bucchieri, F., Pace, A., Piccionello, A. P., & Kayed, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-55419-w · Cited by 73
Synthesis of carbon quantum dots for application of alleviating amyloid-β mediated neurotoxicity
Li, H., Zhang, Y., Ding, J., Wu, T. H., Cai, S., Zhang, W., Cai, R., Chen, C., & Yang, R. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112373 · Cited by 73
5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer’s disease modulate Tau-induced neurotoxicity
Bernstein, A. I., Lin, Y., Street, R. C., Lin, L., Dai, Q., Yu, L., Bao, H., Gearing, M., Lah, J. J., Nelson, P. T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw109 · Cited by 73
High–Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo
Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., Decker, R. D., Buée, L., Boom, A., Leroy, K., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.008 · Cited by 73
MRI-assessed atrophy subtypes in Alzheimer’s disease and the cognitive reserve hypothesis
Persson, K., Eldholm, R. S., Barca, M. L., Cavallin, L., Ferreira, D., Knapskog, A., Selbæk, G., Brækhus, A., Saltvedt, I. T., Westman, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186595 · Cited by 73
Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration
Couttas, T. A., Kain, N., Tran, C., Chatterton, Z., Kwok, J. B., & Don, A. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171054 · Cited by 73
Mitochondrial transport serves as a mitochondrial quality control strategy in axons: Implications for central nervous system disorders
Zheng, Y., Zhang, X., & Chen, Z. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13122 · Cited by 72
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
Sales, T. A., Prandi, I. G., de Castro, A. A., Leal, D. H. S., da Cunha, E. F. F., Kuča, K., & Ramalho, T. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081829 · Cited by 73
Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice
Zhou, Y., Duan, Y., Huang, S., Zhou, X., Zhou, L., Hu, T., Yang, Y., Lu, J., Ding, K., Guo, D., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.177 · Cited by 72
A Personalized Voice-Based Diet Assistant for Caregivers of Alzheimer Disease and Related Dementias: System Development and Validation
Li, J., Maharjan, B., Xie, B., & Tao, C. (2020) · Journal of Medical Internet Research · doi:10.2196/19897 · Cited by 71
Solid-state NMR Reveals a Close Structural Relationship between Amyloid-β Protofibrils and Oligomers
Scheidt, H. A., Morgado, I., & Huster, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367474 · Cited by 71
CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
Eskandari‐Sedighi, G., Jung, J., & Macauley, M. S. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101111 · Cited by 71
Zn impacts Cu coordination to amyloid-β, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity
Aliès, B., Sasaki, I., Proux, O., Sayen, S., Guillon, E., Faller, P., & Hureau, C. (2013) · Chemical Communications · doi:10.1039/c2cc38236a · Cited by 70
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors
Patel, S., Bansoad, A. V., Singh, R., & Khatik, G. L. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211201094031 · Cited by 69
Profiling Microglia through Single-Cell RNA Sequencing over the Course of Development, Aging, and Disease
Pettas, S., Karagianni, K., Kanata, Ε., Chatziefstathiou, A., Christoudia, N., Xanthopoulos, K., Sklaviadis, T., & Dafou, D. (2022) · Cells · doi:10.3390/cells11152383 · Cited by 70
Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption
Ghasemi, R., Zarifkar, A., Rastegar, K., Maghsoudi, N., & Moosavi, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.036 · Cited by 69
Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease
Rozpędek‐Kamińska, W., Markiewicz, Ł., Diehl, J. A., Pytel, D., & Majsterek, I. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150818104254 · Cited by 69
Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes
Fong, L. K., Yang, M. M., dos Santos Chaves, R., Reyna, S. M., Langness, V. F., Woodruff, G., Roberts, E. A., Young, J. E., & Goldstein, L. S. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000441 · Cited by 72
Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
Esposito, M. M., & Sherr, G. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00476 · Cited by 69
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology
Morris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain · doi:10.1093/brain/awac181 · Cited by 68
Self-citation
Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review
Liao, H., Zhu, Z., & Peng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00188 · Cited by 68
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Xu, Q., Boerkoel, P., Hirsch‐Reinshagen, V., Mackenzie, I. R., Hsiung, G. R., Charm, G., To, E., Liu, A., Schwab, K. D., Jiang, K., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01448-y · Cited by 68
GSK3 in Alzheimer's Disease: Mind the Isoforms
Ma, T. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131661 · Cited by 68
Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2
Liu, Y., Deng, Y., Liu, H., Yin, C., Li, X., & Gong, Q. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.11.002 · Cited by 68
Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates
Watanabe, H., Ono, M., Ariyoshi, T., Katayanagi, R., & Saji, H. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00450 · Cited by 68
SAR by kinetics for drug discovery in protein misfolding diseases
Chia, S., Habchi, J., Michaels, T. C. T., Cohen, S. I. A., Linse, S. S., Dobson, C. M., Knowles, T. P. J., & Vendruscolo, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807884115 · Cited by 68
Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 68
Prion-like mechanisms in Alzheimer disease
Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67
The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers
Benítez, B. A., Karch, C. M. M., Cai, Y., Jin, S. C., Cooper, B., Carrell, D., Bertelsen, S. E., Chibnik, L. B., Schneider, J. A., Bennett, D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003685 · Cited by 68
Self-citation
Lead neurotoxicity: exploring the potential impact of lead substitution in zinc-finger proteins on mental health
Ordemann, J. M., & Austin, R. N. (2015) · Metallomics · doi:10.1039/c5mt00300h · Cited by 67
The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice
Stanley, M., Macauley, S. L., Caesar, E. E., Koscal, L. J., Moritz, W., Robinson, G. O., Roh, J., Keyser, J., Jiang, H., & Holtzman, D. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2119-16.2016 · Cited by 67
Self-citation
The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer’s disease—old wine in new bottles
Braunewell, K. H. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00020 · Cited by 66
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease
Mukhopadhyay, S., & Banerjee, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215065 · Cited by 66
Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66
Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1–42 aggregates
Zhaliazka, K., Matveyenka, M., & Kurouski, D. (2023) · FEBS Journal · doi:10.1111/febs.16738 · Cited by 66
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
Tan, L., Wang, H.-F., Tan, M., Tan, C., Zhu, X., Miao, D., Yu, W.-J., Jiang, T., Tan, L., Yu, J., et al. (2016) · Scientific Reports · doi:10.1038/srep26027 · Cited by 66
Self-citation
Abnormal Brain Network Connectivity in a Triple-Network Model of Alzheimer’s Disease
Li, C., Initiative, A. A. D. N., Li, Y., Zheng, L., Zhu, X., Shao, B., Fan, G., Liu, T., & Wang, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181097 · Cited by 65
NEUROINFLAMAÇÃO NA DOENÇA DE ALZHEIMER
Machado, A. P. R., Carvalho, I. O., & Sobrinho, H. M. D. R. (2020) · Revista Brasileira Militar de Ciências · doi:10.36414/rbmc.v6i14.33 · Cited by 67
Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
Ji, H., & Shen, L. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/823201 · Cited by 65
Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway
Liu, P., Zhou, Y., Shi, J.-Z., Wang, F., Yang, X., Zheng, X., Wang, Y., He, Y., Xie, X., & Pang, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154801 · Cited by 67
Epigenetic regulation of estrogen-dependent memory
Fortress, A. M., & Frick, K. M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.001 · Cited by 64
Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer’s Disease
Wiciński, M., Wódkiewicz, E., Słupski, M., Walczak, M., Socha, M. W., Malinowski, B., & Pawlak-Osińska, K. (2018) · BioMed Research International · doi:10.1155/2018/6091014 · Cited by 64
Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease
Wang, X., Zimmermann, H. R., & Ma, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181043 · Cited by 64
The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review
Rifai, O. M., McGrory, S., Robbins, C. B., Grewal, D. S., Liu, A., Fekrat, S., & MacGillivray, T. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12149 · Cited by 63
Human 3D brain organoids: steering the demolecularization of brain and neurological diseases
Adlakha, Y. K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01523-w · Cited by 63
Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling
Lee, I.-S., Jung, K., Kim, I., & Park, K. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.125 · Cited by 63
Chronic Sleep Restriction Induces Aβ Accumulation by Disrupting the Balance of Aβ Production and Clearance in Rats
Zhao, B., Liu, P., Wei, M., Li, Y., Liu, J., Ma, L., Shang, S., Jiang, Y., Huo, K., Wang, J., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02719-2 · Cited by 63
Profiling the oral microbiomes in patients with Alzheimer's disease
Guo, H., Li, B., Yao, H., Liu, D., Chen, R., Zhou, S., Ji, Y., Zeng, L., & Du, M. (2021) · Oral Diseases · doi:10.1111/odi.14110 · Cited by 62
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Dhauria, M., Mondal, R., Deb, S., Shome, G., Chowdhury, D., Sarkar, S., & Benito‐León, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010911 · Cited by 62
Gadolinium-based contrast agents targeted to amyloid aggregates for the early diagnosis of Alzheimer's disease by MRI
Bort, G., Catoen, S., Borderies, H., Kebsi, A., Ballet, S., Louin, G., Port, M., & Ferroud, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.016 · Cited by 62
Nanobiomaterials’ applications in neurodegenerative diseases
Silva‐Adaya, D., Aguirre‐Cruz, L., Guevara, J., & Ortiz-Islas, E. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216659032 · Cited by 62
The Role of KLF4 in Alzheimer’s Disease
Cheng, Z., Zou, X., Jin, Y., Gao, S., Lv, J., Li, B., & Cui, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00325 · Cited by 62
Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: Consequences on extracellular maturation of brain‐derived neurotrophic factor and therapeutic implications
Angelucci, F., Čechová, K., Průša, R., & Hort, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13082 · Cited by 62
RAB10: an Alzheimer’s disease resilience locus and potential drug target
Tavana, J., Rosene, M., Jensen, N., Ridge, P. G., Kauwe, J. S. K., & Karch, C. M. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s159148 · Cited by 62
Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease
Hishimoto, A., Pletnikova, O., Lang, D. L., Troncoso, J. C., Egan, J. M., & Liu, Q.-R. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0475-2 · Cited by 62
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 64
Clinical Genetics of Alzheimer’s Disease
Zou, Z., Liu, C., Che, C., & Huang, H. (2014) · BioMed Research International · doi:10.1155/2014/291862 · Cited by 60
Discovery of a Novel Pharmacological and Structural Class of Gamma Secretase Modulators Derived from the Extract of Actaea racemosa
Findeis, M. A., Schroeder, F. C., McKee, T. D., Yager, D., Fraering, P. C., Creaser, S. P., Austin, W., Clardy, J., Wang, R., Selkoe, D. J., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000857 · Cited by 61
Semantic Feature Training in Combination with Transcranial Direct Current Stimulation (tDCS) for Progressive Anomia
Hung, J., Bauer, A., Grossman, M., Hamilton, R. H., Coslett, H. B., & Reilly, J. J. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00253 · Cited by 61
Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality
Taylor, M. K., Swerdlow, R. H., & Sullivan, D. K. (2019) · Nutrients · doi:10.3390/nu11081910 · Cited by 61
Assessment of the Genetic Architecture of Alzheimer’s Disease Risk in Rate of Memory Decline
Del-Aguila, J. L., Fernández, M. V., Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170834 · Cited by 60
Self-citation
Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s disease
Dhandapani, R., Neri, M., Bernhard, M., Brzak, I., Schweizer, T., Rudin, S., Joller, S., Berth, R., Kernen, J., Neuhaus, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110883 · Cited by 60
Progression of Seed‐Induced A β Deposition within the Limbic Connectome
Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 60
Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implications
Jeon, S. G., Hong, S. B., Nam, Y., Tae, J., Yoo, A., Song, E. J., Kim, K. I., Lee, D., Park, J., Lee, S. M., et al. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100945 · Cited by 60
Complement cascade functions during brain development and neurodegeneration
Fatoba, O., Itokazu, T., & Yamashita, T. (2021) · FEBS Journal · doi:10.1111/febs.15772 · Cited by 59
The AD tau core spontaneously self-assembles and recruits full-length tau to filaments
Carlomagno, Y., Manne, S., Deture, M. A., Prudencio, M., Zhang, Y., Al‐Shaikh, R. H., Dunmore, J. A., Daughrity, L. M., Song, Y., Castanedes‐Casey, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108843 · Cited by 59
Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling
Crompton, L., Byrne, M. L., Taylor, H., Kerrigan, T. L., Bru‐Mercier, G., Badger, J. L., Barbuti, P. A., Jo, J., Tyler, S. J., Allen, S. J., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.08.002 · Cited by 59
Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
Wang, H.-F., Alzheimer’s, D. N. I., Wan, Y., Hao, X., Cao, L., Zhu, X., Jiang, T., Tan, M., Tan, L., Zhang, D., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150972 · Cited by 59
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease
Jensen, C. S., Portelius, E., Siersma, V., Høgh, P., Wermuth, L., Blennow, K., Zetterberg, H., Waldemar, G., Hasselbalch, S. G., & Simonsen, A. H. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000449408 · Cited by 59
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
Gelosa, P., Colazzo, F., Tremoli, E., Sironi, L., & Castiglioni, L. (2017) · Mediators of Inflammation · doi:10.1155/2017/3454212 · Cited by 59
Impaired Spike Timing Dependent Cortico-Cortical Plasticity in Alzheimer’s Disease Patients
Lorenzo, F. D., Ponzo, V., Motta, C., Bonnì, S., Picazio, S., Caltagirone, C., Bozzali, M., Martorana, A., & Koch, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180503 · Cited by 59
Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease
Zhu, L., Xu, L., Wu, X., Dèng, F., Ma, R., Liu, Y., Huang, F., & Shi, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00257 · Cited by 59
Vascular and Metabolic Factors in Alzheimer’s Disease and Related Dementias: Introduction
Iadecola, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0319-y · Cited by 59
Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
Shyam, R., Ren, Y., Lee, J., Braunstein, K. E., Mao, H.-Q., & Wong, P. C. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2015.15 · Cited by 58
Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions
Yamada, K., & Iwatsubo, T. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05225-z · Cited by 62
Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice
MacPherson, R. E. K., Baumeister, P., Peppler, W. T., Wright, D. C., & Little, J. P. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00299.2015 · Cited by 58
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
Wittenberg, R., Knapp, M. R. J., Karagiannidou, M., Dickson, J. C., & Schott, J. M. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.001 · Cited by 58

Authors: Holtzman, D. M., Morris, J. C., & Goate, A. M.
Affiliations: Washington University in St. Louis (US)
ORCID: Holtzman, David M.
Morris, John C.
Goate, Alison M.
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2011-04-06
Volume: 3
Issue: 77
Pages: 77sr1-77sr1
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3002369
PMC: PMC3130546
OpenAlex: W2005483591
Cited by: 1,424
References: 225
Citations by year: 2026: 53 · 2025: 81 · 2024: 99 · 2023: 102 · 2022: 93 · 2021: 93 · 2020: 100 · 2019: 124 · 2018: 116 · 2017: 101 · 2016: 92 · 2015: 95 · 2014: 95 · 2013: 86 · 2012: 69
FWCI: 9.56
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG035083, RC1AG035654, P50AG005681, P01AG003991, R37AG013956, U19AG032438, U01AG032438, R01AG016208, P01AG026276)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, dementia, disease prevalence, pathogenesis, translational research, early detection
MeSH terms: Alzheimer Disease, Humans, Amyloid beta-Peptides, tau Proteins, Disease Progression, Presenilins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer’s Disease: The Challenge of the Second Century

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks